INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
The long, sorry story of Big Pharma’s decline into crime

The long, sorry story of Big Pharma’s decline into crime

Hedley Rees's avatar
Hedley Rees
Sep 22, 2024
∙ Paid
30

Share this post

INSIDE PHARMA
INSIDE PHARMA
The long, sorry story of Big Pharma’s decline into crime
9
5
Share

The SARS-CoV-2 injections scam has its roots in the 1980s. The Big Pharma companies handed over their supply chain assets, and the people working them, to third party companies.

Without a supply chain, you can’t bring new products to market. It was dubbed the valley of death in the early 1990s. The World’s two first blockbuster drugs, Tagamet and Zantac were approved in 1976 and 1981 respectively and their patents ran out in 1994 and 1997. This is the impact on Glaxo (GSK):

“Glaxo's ulcer drug Zantac accounted for 43 per cent of the company's total sales, but when its protective patent expired in 1997, its sales were decimated.”

“Zantac's sales collapsed by 42 per cent to £757 million. It was still the group's biggest seller, but the once-mighty product now accounts for just 9 per cent of Glaxo's total sales. And at the same time Glaxo had to manage the loss of its patent on herpes treatment Zovirax.”

It didn’t get any better.

Pfizer paid $116 Billion for Warner Lambert, a company it had…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share